Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice
- PMID: 20368519
- PMCID: PMC2929562
- DOI: 10.1161/CIRCULATIONAHA.109.924886
Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice
Abstract
Background: T cells play an important role during the immune response that accompanies atherosclerosis. To date, the role for interleukin (IL)-17A in atherogenesis is not well defined. Here, we tested the hypothesis that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells, which in turn promote atherosclerosis.
Methods and results: IL-17A was found to be elevated in the plasma and tissues of apolipoprotein E-deficient (Apoe(-/-)) mice. IL-17A-expressing T cells were significantly increased in the aortas, spleen, and lamina propria of aged Apoe(-/-) mice compared with age-matched C57BL/6 mice. IL-17A(+) T cells resided in both adventitia and aortas of aged Apoe(-/-) mice fed a chow diet. Elevated levels of IL-17A(+) T cells were also detected in the aortas of 21-week-old Apoe(-/-) mice fed a Western diet for 15 weeks. IL-17A(+) T cells were characterized as predominantly CD4(+) T helper 17 (Th17) cells and gammadelta(+) T cells. Blockade of IL-17A in Apoe(-/-) mice by use of adenovirus-produced IL-17 receptor A reduced plaque burden in Apoe(-/-) mice fed a Western diet for 15 weeks. In addition, the treatment diminished circulating IL-6 and granulocyte colony-stimulating factor levels and limited CXCL1 expression and macrophage content within the aortas. Conversely, IL-17A treatment of whole aorta isolated from Apoe(-/-) mice promoted aortic CXCL1 expression and monocyte adhesion in an ex vivo adhesion assay.
Conclusions: These results demonstrate that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells. IL-17A plays a proatherogenic inflammatory role during atherogenesis by promoting monocyte/macrophage recruitment into the aortic wall.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f2a.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f2a.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2929562/bin/nihms198630f5.gif)
Similar articles
-
Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1496-506. doi: 10.1161/ATVBAHA.116.307892. Epub 2016 Jun 30. Arterioscler Thromb Vasc Biol. 2016. PMID: 27365405 Free PMC article.
-
IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.J Immunol. 2014 Nov 1;193(9):4344-55. doi: 10.4049/jimmunol.1400181. Epub 2014 Sep 26. J Immunol. 2014. PMID: 25261478 Free PMC article.
-
The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.Circ Res. 2012 Mar 2;110(5):675-87. doi: 10.1161/CIRCRESAHA.111.261784. Epub 2012 Feb 2. Circ Res. 2012. PMID: 22302786 Free PMC article.
-
Interleukin 17A in atherosclerosis - Regulation and pathophysiologic effector function.Cytokine. 2019 Oct;122:154089. doi: 10.1016/j.cyto.2017.06.016. Epub 2017 Jun 26. Cytokine. 2019. PMID: 28663097 Review.
-
The Two Faces of Interleukin-17A in Atherosclerosis.Curr Drug Targets. 2017;18(7):863-873. doi: 10.2174/1389450117666161229142155. Curr Drug Targets. 2017. PMID: 28034277 Review.
Cited by
-
Cross-talks between perivascular adipose tissue and neighbors: multifaceted nature of nereids.Front Pharmacol. 2024 Aug 2;15:1442086. doi: 10.3389/fphar.2024.1442086. eCollection 2024. Front Pharmacol. 2024. PMID: 39156105 Free PMC article. Review.
-
Inflammation and all-cause mortality in patients undergoing peritoneal dialysis.Einstein (Sao Paulo). 2024 Aug 9;22:eAO0627. doi: 10.31744/einstein_journal/2024AO0627. eCollection 2024. Einstein (Sao Paulo). 2024. PMID: 39140572 Free PMC article.
-
The role of γδT lymphocytes in atherosclerosis.Front Immunol. 2024 May 7;15:1369202. doi: 10.3389/fimmu.2024.1369202. eCollection 2024. Front Immunol. 2024. PMID: 38774876 Free PMC article. Review.
-
The role of immune cells in different stages of atherosclerosis.Int J Med Sci. 2024 Apr 22;21(6):1129-1143. doi: 10.7150/ijms.94570. eCollection 2024. Int J Med Sci. 2024. PMID: 38774746 Free PMC article. Review.
-
Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties.Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1191-1201. doi: 10.1161/ATVBAHA.124.320851. Epub 2024 Apr 25. Arterioscler Thromb Vasc Biol. 2024. PMID: 38660807 Review.
References
-
- Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519. - PubMed
-
- Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G, Xu Q. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 1997;11:1199–1207. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous